Hugh Smyth

Hugh D. C. Smyth is the Alcon Centennial Professor, College of Pharmacy, The University of Texas at Austin. Dr Smyth oversees and multidisciplinary laboratory funded through NIH, FDA, and industry that focuses on engineering new drug delivery systems with an emphasis on drug delivery to the airways. He has over 300 published works which have been cited over 6500 times. Dr Smyth is editor of 3 books, and an inventor on numerous patents or patent applications. He has a Pharmacy and a Ph.D. degree from the University of Otago, New Zealand. He has been faculty at The University of North Carolina at Chapel Hill, and The University of New Mexico. He was the American Association of Pharmaceutical Scientists (AAPS) New Investigator award winner for Pharmaceutics and Pharmaceutical Technologies in 2007. He also received the PhRMA Foundation New Investigator Award in pharmaceutics in 2007. He was the Editor in Chief of Drug Development and Industrial Pharmacy from 2014-2022. Dr. Smyth has started several companies resulting from technologies discovered in his laboratory including Respira Therapeutics, Nob Hill Therapeutics, Via Therapeutics, and Cloxero Therapeutics which are now advancing these technologies for clinical use.